Brawley Otis W insider trades
Brawley Otis W has filed 24 Form 4s with the SEC that we hold, for Lyell Immunopharma, Inc. (LYEL) (Director), Agilent Technologies, INC. (A) (Director), Incyte Corp (INCY) (Director) and PDS Biotechnology Corp (PDSB) (Director). Across all of them we count 1 purchase worth $20.0K and 0 sales worth $0 reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 35,640 shares of Lyell Immunopharma, Inc. worth $20.0K, dated 2025-03-31. The first filing on our record is dated 2021-09-29 and the latest 2026-06-12.
Lyell Immunopharma, Inc. (LYEL)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-03-31 | P, purchase reported on Form 4 | 35,640 | $20.0K | 2025-04-02 |
Agilent Technologies, INC. (A)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Incyte Corp (INCY)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
PDS Biotechnology Corp (PDSB)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1213029) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms